A Real-World Success Story: Meet Maria To understand why semaglutide is making such a difference, lets look at Maria, a 52-year-old mother of three who has lived with type 2 diabetes for nearly a decade
infusion center: For CIDP/MMN patients transitioning to SCIG, educate on self-injection technique, site rotation, recognizing adverse reactions, and storage requirements
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence
We hope youve enjoyed our Fire Station Spotlight videos
CEO David Ricks said the company plans to build out manufacturing capacity for the oral med at risk. I think given the probability we assess internally as well as the opportunity on the other side of a positive phase 3, we see that as a wise investment, Ricks said
For most people who genuinely need them, GLP-1 medicines like Ozempic, Wegovy, and Mounjaro are considered reasonably safe when a doctor supervises the dose
